Acquisition adds complementary asset to the Pelthos commercial portfolioXeglyze is a novel, FDA-approved prescription ...
Children have returned to school and are bringing home stories about the things they learned and the friends they made. But some parents are concerned they could also be bringing home a tiny nuisance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback